-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Chemours, Raises Price Target to $15

Benzinga·07/03/2025 14:40:58
Listen to the news
RBC Capital analyst Arun Viswanathan maintains Chemours (NYSE:CC) with a Outperform and raises the price target from $14 to $15.